New York, New York, January 26, 2026— Rapalogix Health, a biotechnology company advancing a science-first approach to cellular longevity and skin health, announced today that it received the Judges’ Choice Award at Octane’s 7th Annual Aesthetics Tech Forum: Forging the Future of Aesthetics. The award was presented during Octane’s Capital & Growth Company Presentations, a competitive pitch forum recognizing companies with platforms built for long-term clinical relevance. This year’s judging emphasized durability as the true measure of innovation quality, highlighting biology-driven approaches with clear paths to real-world translation. Rapalogix Health...
Read more...
